AF
GBT

Advisornet Financial’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Advisornet Financial’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-125
Closed -$8K – 1938
2020
Q2 		$8K Hold
125
– – ﹤0.01% 1375
2020
Q1 		$6K Hold
125
– – ﹤0.01% 1414
2019
Q4 		$10K Hold
125
– – ﹤0.01% 1392
2019
Q3 		$6K Hold
125
– – ﹤0.01% 1531
2019
Q2 		$7K Hold
125
– – ﹤0.01% 1329
2019
Q1 		$7K Hold
125
– – ﹤0.01% 1269
2018
Q4 		$5K Hold
125
– – ﹤0.01% 1252
2018
Q3 		$5K Buy
+125
New +$5.54K ﹤0.01% 1294

Other funds holding GBT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Advisornet Financial's GBT Position: Q3 2020 in Review

Advisornet Financial sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2020, closing a stake of 125 shares — an estimated $8K sold.

Advisornet Financial first reported a position in GBT in Q3 2018 and held it in 8 quarters. The position peaked at $10K in Q4 2019. 229 funds tracked by Wall St. Rank hold GBT as of Q3 2020.

  • Advisornet Financial reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2020 after selling out during the quarter.
  • Advisornet Financial sold 125 Global Blood Therapeutics, Inc. shares in Q3 2020, an estimated $8K.
  • Advisornet Financial first reported a position in Global Blood Therapeutics, Inc. in Q3 2018 and held it in 8 quarters.
  • Advisornet Financial's Global Blood Therapeutics, Inc. position peaked at $10K in Q4 2019.
  • 229 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2020.

Based on Advisornet Financial's 13F filing for Q3 2020, filed 6 Nov 2020.